Orlando,United States - June 17, 2022 /PressCable/ —
Earlier today, ObvioHealth published content on its website about how digital instruments are transforming electronic patient-reported outcomes within clinical trials. The post addresses various points—from the accuracy of trial endpoints to how these digital instruments are improving the decentralized trial landscape.
Accurate clinical trial endpoints require dependable, high-quality patient-reported outcomes to be achieved. The same holds true for decentralized clinical trials (DCTs). In fact, the digital and virtual components that define DCTs rely heavily on direct participant input and engagement—so much so that it is essential to continuously optimize the data collection process to ensure that electronic patient-reported outcomes (ePRO) translate into clinically validated results.
Digital instruments are altering the electronic patient-reported outcomes in DCTs landscape. Accessible to patients, these tools increase data quality, simplify data collection, and reduce participant burden, enabling researchers to collect more data in real time than ever before.
Although intensified by the global health crisis, the shift towards DCTs has been occurring for years. However, many clinical studies are still conducted using traditional methods: clinicians collect data from patients on-site, frequently using paper questionnaires and in-person interviews.
Despite the fact that this strategy develops confidence between patients and therapists, it is not without flaws. Patients, being human, delay treatment. They complete their trial tasks or fill out their diaries at the last minute, which impairs their ability to recall essential details accurately.
People are also more likely to be performative when they feel like they’re on display or on the spot, reflecting for an audience on what they’ve accomplished or failed to accomplish. Participants may be hesitant to reveal their actual activities and instead report what they believe the researchers want to hear. Consider how simple it is to underreport the number of cocktails you consume per week or to overstate the frequency with which you brush your teeth.
In the next few years, the optimization of electronic patient-reported outcomes will drive the increased use of DCTs and hybrid trials, allowing sponsors and contract research firms to optimize data collection and integrity. However, despite the fact that DCTs have opened the floodgates to data, more data is not the final aim; trial teams must generate better data.
To find out more about ObvioHealth or to read its post see the following URL: https://www.obviohealth.com/
Contact Info:
Name: James Hendrick
Email: Send Email
Organization: ObvioHealth USA, Inc.
Address: 3452 Lake Lynda Drive Suite 151, Orlando, Florida 32817, United States
Phone: +1-888-880-1664
Website: https://www.obviohealth.com/
Source: PressCable
Release ID: 89076907
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.
